Balance Sheet: Assets
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Assets are resources controlled by the company as a result of past events and from which future economic benefits are expected to flow to the entity.
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Common-Size Balance Sheet: Assets
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value (EV)
- Enterprise Value to FCFF (EV/FCFF)
- Capital Asset Pricing Model (CAPM)
- Dividend Discount Model (DDM)
- Selected Financial Data since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Revenues
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Abbott Laboratories, consolidated balance sheet: assets (quarterly data)
US$ in millions
Based on: 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The company’s total assets exhibited a generally increasing trend from March 2021 through December 2025, although with some fluctuations. A notable surge in total assets occurred between September 2024 and December 2025. Analysis of the asset components reveals varying patterns.
- Liquidity – Cash and Short-Term Investments
- Cash and cash equivalents demonstrated volatility, peaking at US$9,799 million in December 2021 and declining to US$6,896 million by December 2023 before recovering to US$8,522 million by December 2025. Short-term investments followed a similar pattern, with a decrease from US$450 million in December 2021 to US$230 million in June 2024, followed by an increase to US$417 million by December 2025. This suggests potential shifts in the company’s investment strategy or liquidity needs.
- Current Assets – Receivables and Inventory
- Trade receivables generally increased over the period, rising from US$6,096 million in March 2021 to US$7,929 million in December 2023, and continuing to US$8,522 million in December 2025. This indicates a potential increase in credit sales or extended payment terms. Inventories also showed an upward trend, increasing from US$5,387 million in March 2021 to US$6,488 million in December 2025, with some quarterly variations. This could reflect increased production levels or changes in supply chain management. Finished products and work in process also increased over the period, while materials fluctuated.
- Long-Term Assets – Property, Plant & Equipment, Intangibles, and Goodwill
- Net property and equipment experienced a steady increase from US$8,832 million in March 2021 to US$11,816 million in December 2025, suggesting ongoing investments in fixed assets. Intangible assets, net of amortization, decreased consistently throughout the period, falling from US$14,181 million in March 2021 to US$5,526 million in December 2025. Goodwill also exhibited a slight decline initially, then increased to US$24,035 million in December 2025. Deferred income taxes and other assets showed a significant increase, particularly between September 2024 and December 2025, rising from US$8,011 million to US$18,422 million.
The combined effect of these trends resulted in a substantial increase in total assets towards the end of the observed period. The growth in long-term assets, particularly deferred income taxes, contributed significantly to this increase. The fluctuations in cash and short-term investments suggest active liquidity management, while the increases in receivables and inventory may warrant further investigation into sales and operational efficiency.